Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America
Author
dc.contributor.author
Cesar, Carina
Author
dc.contributor.author
Koethe, Jonh R.
Author
dc.contributor.author
Giganti, Mark J.
Author
dc.contributor.author
Rebeiro, Peter F.
Author
dc.contributor.author
Althoff, Keri N.
Author
dc.contributor.author
Napravnik, Sonia
Author
dc.contributor.author
Mayor, Ángel
Author
dc.contributor.author
Grinsztejn, Beatriz
Author
dc.contributor.author
Wolff Reyes, Marcelo
Author
dc.contributor.author
Padgett, Denis
Author
dc.contributor.author
Sierra Madero, Juan Juan
Author
dc.contributor.author
Gotuzzo, Eduardo
Author
dc.contributor.author
Sterling, Timothy R.
Author
dc.contributor.author
Willig, James
Author
dc.contributor.author
Levison, Julie
Author
dc.contributor.author
Kitahata, Mari
Author
dc.contributor.author
Rodríguez Barradas, María
Author
dc.contributor.author
Moore, Richard D.
Author
dc.contributor.author
McGowan, Catherine
Author
dc.contributor.author
Shepherd, Bryan E.
Author
dc.contributor.author
Cahn, Pedro
Admission date
dc.date.accessioned
2016-10-27T19:13:16Z
Available date
dc.date.available
2016-10-27T19:13:16Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Journal of the International AIDS Society 2016, 19:20684
es_ES
Identifier
dc.identifier.other
10.7448/IAS.19.1.20684
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/141053
Abstract
dc.description.abstract
Introduction: Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of the care continuum, whereas in Latin America antiretroviral therapy (ART) services continue to expand to meet treatment needs. In this analysis, we compare HIV treatment outcomes between Latinos receiving ART in North America versus Latin America.
Methods: HIV-positive adults initiating ART at Caribbean, Central and South America Network for HIV (CCASAnet) sites were compared to Latino patients (based on country of origin or ethnic identity) starting treatment at North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) sites in the United States and Canada between 2000 and 2011. Cox proportional hazards models compared mortality, treatment interruption, antiretroviral regimen change, virologic failure and loss to follow-up between cohorts.
Results: The study included 8400 CCASAnet and 2786 NA-ACCORD patients initiating ART. CCASAnet patients were younger (median 35 vs. 37 years), more likely to be female (27% vs. 20%) and had lower nadir CD4 count (median 148 vs. 195 cells/mu L, p<0.001 for all). In multivariable analyses, CCASAnet patients had a higher risk of mortality after ART initiation (adjusted hazard ratio (AHR) 1.61; 95% confidence interval (CI): 1.32 to 1.96), particularly during the first year, but a lower hazard of treatment interruption (AHR: 0.46; 95% CI: 0.42 to 0.50), change to second-line ART (AHR: 0.56; 95% CI: 0.51 to 0.62) and virologic failure (AHR: 0.52; 95% CI: 0.48 to 0.57).
Conclusions: HIV-positive Latinos initiating ART in Latin America have greater continuity of treatment but are at higher risk of death than Latinos in North America. Factors underlying these differences, such as HIV testing, linkage and access to care, warrant further investigation.